Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease is caused by a single genetic mutation that creates a fusion protein.
Immune cell protein identified as potential target for rare liver cancer treatment
- Post author:
- Post published:March 20, 2024
- Post category:uncategorized